PLSE Pulse Biosciences Inc

Pulse Biosciences Inc is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.

As of 06/28/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  05/18/2016
Outstanding shares:  29,802,280
Average volume:  188,150
Market cap:   $57,816,423
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD02SG8
Valuation   (See tab for details)
PE ratio:   -1.23
PB ratio:   2.78
PS ratio:   31.05
Return on equity:   -299.55%
Net income %:   -3,345.54%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy